Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil and Alprostadil for Erectile Dysfunction Recovery After Prostatectomy
NCT00544076Phase 3Terminated
- Sponsor
- City of Hope
- Start
- Jan 2006
- Primary completion
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ASP-001, Vasostenoon in erectile dysfunction (ED), sponsored by City of Hope. Started Jan 2006; status: terminated.
02
Drugs
ASP-001Vasostenoon
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT00544076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00544076.